A phase II study evaluating CAVi (cyclophosphamide, adriamycin, vincristine) potentiated or not by amphotericin B entrapped into sonicated liposomes, as salvage therapy for small cell lung cancer
- 31 October 1990
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 6 (3-4), 110-118
- https://doi.org/10.1016/0169-5002(90)90114-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancerAnnals of Oncology, 1990
- Mechanism of multidrug resistanceBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1988
- Pilot study of amphotericin B entrapped in sonicated liposomes in cancer patients with fungal infectionsEuropean Journal of Cancer and Clinical Oncology, 1988
- Superiority of Alternating Non-Cross-Resistant Chemotherapy in Extensive Small Cell Lung CancerAnnals of Internal Medicine, 1987
- Review: Small-Cell Lung Cancer: Current PerspectivesThe American Journal of the Medical Sciences, 1987
- Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer.Journal of Clinical Oncology, 1985
- Cyclic alternating 'non-cross resistant' chemotherapy in the management of small cell anaplastic carcinoma of the lungCancer Treatment Reviews, 1984
- Effects of amphotericin B on combination chemotherapy of metastatic sarcomasCancer, 1984
- Combined modality treatment of small cell carcinoma of the lungArchives of Internal Medicine, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958